TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers With a Favorable Prognosis

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-2051
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

TMPRSS2-ERG Gene Fusion in Transition Zone Prostate Cancer

Modern Pathology
Forensic MedicinePathology
2010English

Diversity of TMPRSS2-ERG Fusion Transcripts in the Human Prostate

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Absence of TMPRSS2:ERG Fusions and PTEN Losses in Prostate Cancer Is Associated With a Favorable Outcome

Modern Pathology
Forensic MedicinePathology
2008English

Loss of the Adhesion Molecule CEACAM1 Is Associated With Early Biochemical Recurrence in TMPRSS2:ERG Fusion Positive Prostate Cancers

International Journal of Cancer
Cancer ResearchOncology
2020English

Prostate Cancer of Transition Zone Origin Lacks TMPRSS2–ERG Gene Fusion

Modern Pathology
Forensic MedicinePathology
2009English

Pathologie: La Fusion Génique TMPRSS2-ERG Dans Le Cancer De La Prostate

Forum Médical Suisse ‒ Swiss Medical Forum
2011English

TMPRSS2-ERG Fusion Is Frequently Observed in Gleason Pattern 3 Prostate Cancer in a Canadian Cohort

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

The Presence of Stromal Mast Cells Identifies a Subset of Invasive Breast Cancers With a Favorable Prognosis

Modern Pathology
Forensic MedicinePathology
2004English

Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene in Prostate Cancer Using Liposomal Nanotechnology

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy